{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:07:15Z","timestamp":1790381235902,"version":"4.1.0"},"reference-count":30,"publisher":"Scientific Scholar","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,4]]},"abstract":"<jats:sec>\n            <jats:title>Background &amp; objectives:<\/jats:title>\n            <jats:p>Vitiligo is an acquired skin disease characterized by depigmented areas of the skin. Increased release of catecholamines from autonomic nerve endings in microenvironment of melanocytes in affected skin might be involved in the aetiopathogenesis of vitiligo. Levels of catecholamines are considered as being related to onset or worsening of the disease. Therefore, in this study, the role of catecholamines was evaluated in mapping disease stability and outcome of vitiligo patients undergoing melanocyte transfer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>In this study, circulatory and urinary levels of catecholamine (CA) and vanillylmandelic acid (VMA) were determined in 45 individuals (30 vitiligo patients and 15 healthy controls) using ELISA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A significant increase for plasma and urinary catecholamines along with VMA was observed as compared to healthy controls. When the pre- and post-intervention levels were analyzed in responders and non-responders, respectively, only dopamine showed significant decline in urine, rest of the molecules in plasma as well as urine showed non-significant decline except VMA which showed insignificant increase.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interpretation &amp; conclusions:<\/jats:title>\n            <jats:p>Levels of plasma\/urinary epinephrine, and plasma dopamine, could not be established as biomarkers for disease stability or successful outcome of autologous melanocyte transfer in generalized vitiligo patients. However, dopamine (urine) might be of help in determining the stability in patients with generalized vitiligo undergoing melanocyte transfer. Further studies need to be done on a large sample of patients to confirm our findings.<\/jats:p>\n          <\/jats:sec>","DOI":"10.4103\/ijmr.ijmr_657_16","type":"journal-article","created":{"date-parts":[[2018,7,10]],"date-time":"2018-07-10T09:41:06Z","timestamp":1531215666000},"page":"384-390","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["Plasma &amp; urinary catecholamines &amp; urinary vanillylmandelic acid levels in patients with generalized vitiligo"],"prefix":"10.25259","volume":"147","author":[{"given":"Binamra","family":"Basnet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Bhushan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehan","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guresh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod Kumar","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpana","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somesh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"R1-10-20241212","first-page":"526","article-title":"Vitiligo: Pathomechanisms and genetic polymorphism of susceptible genes","volume":"44","author":"Shajil","year":"2006","journal-title":"Indian J Exp Biol"},{"key":"R2-10-20241212","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH659>3.0.CO;2-D","article-title":"Melanocytes are not absent in lesional skin of long duration vitiligo","volume":"191","author":"Tobin","year":"2000","journal-title":"J Pathol"},{"key":"R3-10-20241212","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1600-0749.2007.00399.x","article-title":"Vitiligo puzzle: The pieces fall in place","volume":"20","author":"Westerhof","year":"2007","journal-title":"Pigment Cell Res"},{"key":"R4-10-20241212","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-0749.1992.tb00003.x","article-title":"Catecholamines and vitiligo","volume":"5","author":"Morrone","year":"1992","journal-title":"Pigment Cell Res"},{"key":"R5-10-20241212","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1034\/j.1600-0749.2000.130106.x","article-title":"Higher plasma catecholamine and metabolite levels in the early phase of nonsegmental vitiligo","volume":"13","author":"Cucchi","year":"2000","journal-title":"Pigment Cell Res"},{"key":"R6-10-20241212","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00403-009-0964-4","article-title":"Circulatory levels of antioxidants and lipid peroxidation in Indian patients with generalized and localized vitiligo","volume":"301","author":"Khan","year":"2009","journal-title":"Arch Dermatol Res"},{"key":"R7-10-20241212","first-page":"74","article-title":"Catecholamine level and its relation to anxiety and depression in patients with vitiligo","volume":"6","author":"Zaki","year":"2009","journal-title":"J Egypt Women Dermatol Soc"},{"key":"R8-10-20241212","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1046\/j.1524-4725.2000.00050.x","article-title":"Suction blister induction time: 15 minutes or 150 minutes?","volume":"26","author":"Gupta","year":"2000","journal-title":"Dermatol Surg"},{"key":"R9-10-20241212","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jaad.2004.06.041","article-title":"Surgical pearl: Standardized suction syringe for epidermal grafting","volume":"52","author":"Gupta","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R10-10-20241212","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/jid.1968.15","article-title":"Suction blister device for separation of viable epidermis from dermis","volume":"50","author":"Kiistala","year":"1968","journal-title":"J Invest Dermatol"},{"key":"R11-10-20241212","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000051626","article-title":"Surgical techniques for vitiligo: A review","volume":"202","author":"van Geel","year":"2001","journal-title":"Dermatology"},{"key":"R12-10-20241212","first-page":"33","article-title":"A novel scoring system for evaluation of results of autologous transplantation methods in vitiligo","volume":"68","author":"Gupta","year":"2002","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R13-10-20241212","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1046\/j.1365-4362.1998.00437.x","article-title":"Autologous epidermal grafting with PUVA-irradiated donor skin for the treatment of vitiligo","volume":"37","author":"Lee","year":"1998","journal-title":"Int J Dermatol"},{"key":"R14-10-20241212","first-page":"565","article-title":"Treatment of vitiligo with suction epidermal grafting by the use of an ultrapulse CO2 laser with a computerized pattern generator","volume":"27","author":"Oh","year":"2001","journal-title":"Dermatol Surg"},{"key":"R15-10-20241212","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1046\/j.1365-4362.2000.00989.x","article-title":"Suction blister grafting for stable vitiligo using pulsed erbium: YAG laser ablation for recipient site","volume":"39","author":"Sachdev","year":"2000","journal-title":"Int J Dermatol"},{"key":"R16-10-20241212","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/j.1365-2133.2012.10886.x","article-title":"Study of clinical, biochemical and immunological factors determining stability of disease in patients with generalized vitiligo undergoing melanocyte transplantation","volume":"166","author":"Rao","year":"2012","journal-title":"Br J Dermatol"},{"key":"R17-10-20241212","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jaad.2011.07.018","article-title":"Circulatory levels of T-cell cytokines (interleukin [IL]-2, IL-4, IL-17, and transforming growth factor-\u03b2) in patients with vitiligo","volume":"66","author":"Khan","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"R18-10-20241212","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1067\/mjd.2003.415","article-title":"Epidermal grafting in vitiligo: Influence of age, site of lesion, and type of disease on outcome","volume":"49","author":"Gupta","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"R19-10-20241212","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/0974-2077.53101","article-title":"Stability in vitiligo: Why such a hullabaloo?","volume":"2","author":"Gupta","year":"2009","journal-title":"J Cutan Aesthet Surg"},{"key":"R20-10-20241212","first-page":"147","article-title":"The mechanisms of action of phototherapy in the treatment of the most common dermatoses","volume":"35","author":"Bulat","year":"2011","journal-title":"Coll Antropol"},{"key":"R21-10-20241212","first-page":"14","article-title":"Detection of plasma and urinary monoamines and their metabolites in nonsegmental vitiligo","volume":"20","author":"Shahin","year":"2012","journal-title":"Acta Dermatovenerol Croat"},{"key":"R22-10-20241212","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/1523-1747.ep12335801","article-title":"Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo","volume":"109","author":"Maresca","year":"1997","journal-title":"J Invest Dermatol"},{"key":"R23-10-20241212","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0891-5849(89)90045-2","article-title":"Free radical reduction in the human epidermis","volume":"6","author":"Schallreuter","year":"1989","journal-title":"Free Radic Biol Med"},{"key":"R24-10-20241212","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12402-015-0166-1","article-title":"Possible atomoxetine-induced vitiligo: A case report","volume":"7","author":"Bilgi\u00e7","year":"2015","journal-title":"Atten Defic Hyperact Disord"},{"key":"R25-10-20241212","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1600-0749.1996.tb00098.x","article-title":"Vitiligo, psoralen, and melanogenesis: Some observations and understanding","volume":"9","author":"Chakraborty","year":"1996","journal-title":"Pigment Cell Res"},{"key":"R26-10-20241212","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0190-9622(88)70168-1","article-title":"Biology of hypopigmentation","volume":"19","author":"Bolognia","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"R27-10-20241212","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1034\/j.1600-0749.2003.00015.x","article-title":"Catecholamines increase in the urine of non-segmental vitiligo especially during its active phase","volume":"16","author":"Cucchi","year":"2003","journal-title":"Pigment Cell Res"},{"key":"R28-10-20241212","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000338023","article-title":"Expression profile of genes associated with the dopamine pathway in vitiligo skin biopsies and blood sera","volume":"224","author":"Reimann","year":"2012","journal-title":"Dermatology"},{"key":"R29-10-20241212","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jdermsci.2011.03.007","article-title":"Apigenin attenuates dopamine-induced apoptosis in melanocytes via oxidative stress-related p38, c-Jun NH2-terminal kinase and Akt signaling","volume":"63","author":"Lin","year":"2011","journal-title":"J Dermatol Sci"},{"key":"R30-10-20241212","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4161\/oxim.3.3.12114","article-title":"Potential redox-sensitive Akt activation by dopamine activates Bad and promotes cell death in melanocytes","volume":"3","author":"Choi","year":"2010","journal-title":"Oxid Med Cell Longev"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/02223309-201847040-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T23:00:12Z","timestamp":1751497212000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/plasma-urinary-catecholamines-urinary-vanillylmandelic-acid-levels-in-patients-with-generalized-vitiligo\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmr.ijmr_657_16","relation":{},"ISSN":["0971-5916"],"issn-type":[{"value":"0971-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]}}}